Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-07-08

Clinical Trial Update: Hepatitis B Vaccine Predialysis/Dialysis Study (V232-060) [Phase 3]

View source ↗

Summary

A Phase 3 trial of a Hepatitis B vaccine in predialysis and dialysis patients completed with results posted in 2009.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hepatitis B vaccine (V232-060) (Hepatitis B vaccine)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Hepatitis B Virus Infection | Phase 3 | Status: COMPLETED | Results posted: 2009-07-08